Hettinga Ymkje M, Scheerlinck Laura M E, Lilien Marc R, Rothova Aniki, de Boer Joke H
Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands.
Department of Pediatric Nephrology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
JAMA Ophthalmol. 2015 Feb;133(2):140-5. doi: 10.1001/jamaophthalmol.2014.4301.
Tubulointerstitial nephritis and uveitis (TINU) syndrome is characterized by tubulointerstitial and ocular inflammation. Thus far, the value of noninvasive diagnostic tests is not known.
To determine whether urinary β2-microglobulin (β2M), urinary protein, and serum creatinine have predictive value for detecting TINU syndrome in young patients with uveitis.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted July 2010 through February 2013 at a tertiary care referral center in Utrecht, the Netherlands. Forty-five consecutive new patients with uveitis aged 22 years or younger were enrolled.
Urinary β2M, urinary protein, and serum creatinine were measured prospectively, and the estimated glomerular filtration rate was calculated.
A post hoc analysis was performed to determine whether urinary β2M, urinary protein, serum creatinine, estimated glomerular filtration rate, and/or pyuria were correlated with definitive and probable cases of TINU syndrome.
Eighteen of the 45 patients (40%) in our cohort had elevated urinary β2M levels, and 10 patients (22%) had elevated serum creatinine levels. Twenty of 43 patients (47%) had proteinuria. Eight of the 45 patients were diagnosed by a pediatric nephrologist as having renal dysfunction that suggested acute interstitial nephritis. Of these 8 patients, 2 were definitively diagnosed as having TINU syndrome (confirmed by renal biopsy). After excluding other causes of renal dysfunction, the remaining 6 patients with uveitis and renal dysfunction fulfilled the criteria of probable TINU syndrome. The 8 patients with definitive or probable TINU syndrome had higher urinary β2M levels than patients with normal renal function (median β2M, 1.95 mg/L; 95% CI, 1.26-5.16 mg/L vs 0.20 mg/L; 95% CI, 0.19-0.21 mg/L; P < .001; Mann-Whitney U test). Our analysis revealed that the positive predictive value of increased β2M combined with increased serum creatinine was 100% for detecting definitive and/or probable TINU syndrome.
These data suggest that urinary β2M and serum creatinine levels are sensitive and relatively simple diagnostic screening tools for detecting renal dysfunction to diagnose TINU syndrome in young patients with uveitis similar to those evaluated in this study.
肾小管间质性肾炎和葡萄膜炎(TINU)综合征的特征是肾小管间质和眼部炎症。到目前为止,非侵入性诊断测试的价值尚不清楚。
确定尿β2-微球蛋白(β2M)、尿蛋白和血清肌酐对检测葡萄膜炎年轻患者的TINU综合征是否具有预测价值。
设计、地点和参与者:这项前瞻性队列研究于2010年7月至2013年2月在荷兰乌得勒支的一家三级医疗转诊中心进行。连续纳入45名年龄在22岁及以下的新发葡萄膜炎患者。
前瞻性测量尿β2M、尿蛋白和血清肌酐,并计算估计的肾小球滤过率。
进行事后分析,以确定尿β2M、尿蛋白、血清肌酐、估计的肾小球滤过率和/或脓尿是否与TINU综合征的确诊病例和疑似病例相关。
我们队列中的45名患者中有18名(40%)尿β2M水平升高,10名患者(22%)血清肌酐水平升高。43名患者中有20名(47%)有蛋白尿。45名患者中有8名被儿科肾病学家诊断为肾功能不全,提示急性间质性肾炎。在这8名患者中,2名被确诊为TINU综合征(经肾活检证实)。在排除其他肾功能不全原因后,其余6名葡萄膜炎和肾功能不全患者符合疑似TINU综合征的标准。8名确诊或疑似TINU综合征的患者尿β2M水平高于肾功能正常的患者(β2M中位数,1.95mg/L;95%CI,1.26 - 5.16mg/L对0.20mg/L;95%CI,0.19 - 0.21mg/L;P <.001;Mann-Whitney U检验)。我们的分析显示,β2M升高与血清肌酐升高相结合对检测确诊和/或疑似TINU综合征的阳性预测值为100%。
这些数据表明,尿β2M和血清肌酐水平是检测肾功能不全的敏感且相对简单的诊断筛查工具,可用于诊断本研究中所评估的类似葡萄膜炎年轻患者的TINU综合征。